483sOnline Subscribe

Search By Date Issued

Search By Category

Drug
Device
Clinical

Search By Company/

Clinical Investigator

Search By Region

Search By FDA Investigator

Search By Keyword

Log in to start searching through our library of thousands of 483s, or Subscribe Now to 483sOnline.com to uncover exactly what FDA Inspectors are thinking about. It’s your own personal pre-investigation intelligence tool that identifies exactly what investigators are focusing on so you can be prepared – before they show up.

Dixon Investments, Inc. - March 22, 2019

Issue Date

Mar 22, 2019

Region

Southeast

Category

Drug
$117.00

Dixon Investments, Inc.

Contact Name

John Gordon Dixon

Contact Title

President/Owner

Form483 Address 1

2523 S. Mcdonough Rd.

Form483 Address 2

Form483 City

Orchard Hill

Form483 State

GA

Form483 Postal

30266

Form483 Country

United States

Inspection Range

Mar 19, 2019 - Mar 22, 2019

Pages

5

First Observation

Control procedures are not established which validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product.
Investigator(s): Susan O. Oladeji